Rein Therapeutics, Inc. Common Stock RNTX Balance Sheet Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $4.45M+38.3% | $3.22M-20.6% | $4.05M-29.3% | $5.72M-23.0% | $7.43M-42.3% | ||
| $1.01M-9.3% | $1.11M-1.3% | $1.13M+28.0% | $880K-2.5% | $903K+14.0% | ||
| $5.45M+26.1% | $4.33M-16.4% | $5.17M-21.6% | $6.6M-20.8% | $8.33M-39.0% | ||
| —— | $0— | $0-100% | $1K0.0% | $1K0.0% | ||
| $6.33M0.0% | $6.33M0.0% | $6.33M0.0% | $6.33M0.0% | $6.33M0.0% | ||
| $13.5M0.0% | $13.5M-68.0% | $42.2M0.0% | $42.2M0.0% | $42.2M0.0% | ||
| $1.06M0.0% | $1.06M-40.2% | $1.77M0.0% | $1.77M0.0% | $1.77M0.0% | ||
| $1.01M+50,150% | $2K0.0% | $2K-99.9% | $2.35M+206% | $766K+38,200% | ||
| $26.29M+8.8% | $24.16M-55.0% | $53.71M-6.6% | $57.48M-0.3% | $57.63M-7.3% | ||
| $6.26M+57.5% | $3.98M-3.6% | $4.12M-31.6% | $6.03M+425% | $1.15M+26.1% | ||
| $2.45M+11.2% | $2.2M+36.0% | $1.62M-2.7% | $1.67M-65.5% | $4.83M-0.2% | ||
| $13.64M+121% | $6.18M+7.6% | $5.74M-25.3% | $7.69M+28.7% | $5.98M+4.0% | ||
| —— | $0— | $0— | —— | —— | ||
| $14.7M+103% | $7.24M-3.7% | $7.52M-20.6% | $9.47M+22.2% | $7.75M-0.6% | ||
| $114K+0.9% | $113K+1.8% | $111K+1.8% | $109K+0.9% | $108K0.0% | ||
| $373.64M+0.1% | $373.13M+0.7% | $370.42M+1.0% | $366.64M+1.4% | $361.7M+0.3% | ||
| -$407.11M-1.5% | -$401.27M-8.7% | -$369.3M-1.5% | -$363.72M-1.9% | -$356.9M-1.6% | ||
| -$62K0.0% | -$62K-40.9% | -$44K0.0% | -$44K-37.5% | -$32K-77.8% | ||
| $26.29M+8.8% | $24.16M-55.0% | $53.71M-6.6% | $57.48M-0.3% | $57.63M-7.3% | ||
| $1.01M+50,150% | $2K0.0% | $2K-99.9% | $2.35M+206% | $766K+38,200% | ||
| $13.5M0.0% | $13.5M-68.0% | $42.2M0.0% | $42.2M0.0% | $42.2M0.0% | ||
| $1.01M+50,150% | $2K0.0% | $2K-99.9% | $2.35M+206% | $766K+38,200% | ||
| $1.01M+50,150% | $2K0.0% | $2K-99.9% | $2.35M+206% | $766K+38,200% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| $2.45M+11.2% | $2.2M+36.0% | $1.62M-2.7% | $1.67M-65.5% | $4.83M-0.2% | ||
| $373.64M+0.1% | $373.13M+0.7% | $370.42M+1.0% | $366.64M+1.4% | $361.7M+0.3% | ||
| $114K+0.9% | $113K+1.8% | $111K+1.8% | $109K+0.9% | $108K0.0% | ||
| $1.06M0.0% | $1.06M-40.2% | $1.77M0.0% | $1.77M0.0% | $1.77M0.0% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Rein Therapeutics, Inc. Common Stock's total assets?
- Rein Therapeutics, Inc. Common Stock (RNTX) holds $26.3M in total assets, down 54.4% year over year.
- How much cash does Rein Therapeutics, Inc. Common Stock have?
- Rein Therapeutics, Inc. Common Stock holds $4.4M in cash and equivalents.
- Can Rein Therapeutics, Inc. Common Stock cover its short-term obligations?
- Its current ratio is 0.40 — current liabilities exceed current assets.
- Where does Rein Therapeutics, Inc. Common Stock's balance sheet data come from?
- Every line is extracted from Rein Therapeutics, Inc. Common Stock's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.